PMCC Resources

Here are the staff publications for December 2016, compiled January 24th.

  1. Beach JA, Bowtell DD. Commentary on "Epithelial-to-Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer". Cancer Research 2016;76:7075-7.
  2. Colebatch AJ, Di Stefano L, Wong SQ, et al. Clustered somatic mutations are frequent in transcription factor binding motifs within proximal promoter regions in melanoma and other cutaneous malignancies. Oncotarget 2016;7:66569-85.
  3. Darb-Esfahani S, Denkert C, Stenzinger A, et al. Role of TP53 mutations in triple negative and HER2-positive breast cancer treated with neoadjuvant anthracycline/taxane-based chemotherapy. Oncotarget 2016;7:67686-98.
  4. Davydova N, Harris NC, Roufail S, et al. Differential Receptor Binding and Regulatory Mechanisms for the Lymphangiogenic Growth Factors Vascular Endothelial Growth Factor (VEGF)-C and -D. Journal of Biological Chemistry 2016;291:27265-78.
  5. Flies AS, Lyons AB, Corcoran LM, et al. PD-L1 Is Not Constitutively Expressed on Tasmanian Devil Facial Tumor Cells but Is Strongly Upregulated in Response to IFN-gamma and Can Be Expressed in the Tumor Microenvironment. Frontiers in Immunology 2016;7:581.
  6. Gebhardt T, Harvey KF. Hippo Wades into Cancer Immunology. Developmental Cell 2016;39:635-7.
  7. Godtman RA, Stranne J, Hugosson J. Reply from Authors re: Roderick C.N. van den Bergh, Declan G. Murphy, Henk G. van der Poel. Expectant Management for Prostate Cancer: Lessons from the Past, Challenges for the Future. Eur Urol 2016;70:767-8. European Urology 2016;70:769-70.
  8. Hawkins ED, Duarte D, Akinduro O, et al. T-cell acute leukaemia exhibits dynamic interactions with bone marrow microenvironments. Nature 2016;538:518-22.
  9. Hendry SA, Farnsworth RH, Solomon B, Achen MG, Stacker SA, Fox SB. The Role of the Tumor Vasculature in the Host Immune Response: Implications for Therapeutic Strategies Targeting the Tumor Microenvironment. Frontiers in Immunology 2016;7:621.
  10. Kang J, Kusnadi EP, Ogden AJ, et al. Amino acid-dependent signaling via S6K1 and MYC is essential for regulation of rDNA transcription. Oncotarget 2016;7:48887-904.
  11. Keehan S, Taylor ML, Smith RL, Dunn L, Kron T, Franich RD. Dose and Gamma-Ray Spectra from Neutron-Induced Radioactivity in Medical Linear Accelerators Following High-Energy Total Body Irradiation. Radiation Protection Dosimetry 2016;172:327-32.
  12. Kim TH, Gill NK, Nyberg KD, et al. Cancer cells become less deformable and more invasive with activation of beta-adrenergic signaling. Journal of Cell Science 2016;129:4563-75.
  13. Lawrence N, Martin A, Toner G, et al. Long-term outcomes of accelerated BEP (bleomycin, etoposide, cisplatin) for advanced germ cell tumours: updated analysis of an Australian multicentre phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP). Annals of Oncology 2016;27:2302-3.
  14. Lawrentschuk N, Walsh PC. Reply to Filippo Alongi, Rosario Mazzola, Sergio Fersino's Letter to the Editor re: Patrick C. Walsh, Nathan Lawrentschuk. Immediate Adjuvant Radiation Therapy Following Radical Prostatectomy Should Not Be Advised for Men with Extraprostatic Extension Who Have Negative Surgical Margins. Eur Urol 2016;69:191-2. European Urology 2016;70:e162.
  15. Liu DS, Hoefnagel SJ, Fisher OM, et al. Novel metastatic models of esophageal adenocarcinoma derived from FLO-1 cells highlight the importance of E-cadherin in cancer metastasis. Oncotarget 2016;7:83342-58.
  16. Lobachevsky P, Leong T, Daly P, et al. Compromized DNA repair as a basis for identification of cancer radiotherapy patients with extreme radiosensitivity. Cancer Letters 2016;383:212-9.
  17. Perera M, Papa N, Christidis D, et al. Sensitivity, Specificity, and Predictors of Positive 68Ga-Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis. European Urology 2016;70:926-37.
  18. Quin J, Chan KT, Devlin JR, et al. Inhibition of RNA polymerase I transcription initiation by CX-5461 activates non-canonical ATM/ATR signaling. Oncotarget 2016;7:49800-18.
  19. Savas P, Teo ZL, Lefevre C, et al. The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program "CASCADE". PLoS medicine 2016;13:e1002204.
  20. Sutton SK, Carter DR, Kim P, et al. A novel compound which sensitizes BRAF wild-type melanoma cells to vemurafenib in a TRIM16-dependent manner. Oncotarget 2016;7:52166-78.
  21. Szasz AM, Lanczky A, Nagy A, et al. Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients. Oncotarget 2016;7:49322-33.
  22. Tan LY, Mintoff C, Johan MZ, et al. Desmoglein 2 promotes vasculogenic mimicry in melanoma and is associated with poor clinical outcome. Oncotarget 2016;7:46492-508.
  23. Tiong A, Lao L, MacKean J, Goonetilleke M, Kron T. Faculty of Radiation Oncology Position Paper on the use of Image-Guided Radiation Therapy. Journal of Medical Imaging and Radiation Oncology 2016;60:772-80.
  24. van den Bergh RC, Murphy DG, van der Poel HG. Expectant Management for Prostate Cancer: Lessons from the Past, Challenges for the Future. European Urology 2016;70:767-8.

Health Sciences Library [MAP]

PO Royal Melbourne Hospital

PARKVILLE, VIC 3050, AUSTRALIA

Phone: (03) 9342 8617; Fax: (03) 9342 8615

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Learning Resource Centre [MAP]

Level 7A, Peter MacCallum Cancer Centre

305 Grattan Street

MELBOURNE, VIC 3000, AUSTRALIA

Phone: (03) 8559 7194

 

Library Manager

Susan Monaghan;

Phone: (03) 9342 7346

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Health Sciences Library (RMH Building)

Hours (February - November):

Monday - Thursday: 8.30am - 6pm

Friday: 8.30am - 5pm

Summer Hours (December - January):

Monday - Friday: 8:30am - 5pm 


Learning Resource Centre (Peter MacCallum Building)

Staffed Hours (January - December):

Monday - Thursday: 10am - 2pm